Elanco Animal Health Inc (ELAN): Operating Cash Flow
$560.00M
Year ended 2025-12-31
$617.00M
Trailing 12 months to 2026-06-30
+7.4%
3-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $560.00M | +3.5% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $541.00M | +99.6% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $271.00M | -40.0% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $452.00M | -6.4% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $483.00M | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$41.00M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $224.00M | -54.0% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $487.30M | +180.4% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $173.80M | +11.5% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $155.90M | n/a | 2019-02-20, From 2016-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $560.00M | +3.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.36B | -2.9% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $238.50M | -34.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $1.13B | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $524.08M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $700.00M | -25.5% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $827.99M | +44.5% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | +17.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $339.99M | +15.2% |
Compare ELAN, JAZZ, PRGO, ONC side by side · Screen every company in Pharmaceutical Preparations ↗